HALISTER: CVS Targets Valeant’s $1,000 Nail Fungus Drug With Restrictions

CVS Targets Valeant’s $1,000 Nail Fungus Drug With Restrictions

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
VRX CN (Valeant Pharmaceuticals International Inc)
CVS US (CVS Health Corp)

People
Troyen Brennan (CVS Health Corp)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283